| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10967799 | Vaccine | 2012 | 8 Pages |
Abstract
⺠rMV vector immunization primes cellular responses to an adenovirus vector heterologous boost. ⺠rMV priming is highly effective for suboptimal doses of the boosting vector. ⺠Recombinant MV retains robust measles-specific humoral and cellular immunogenicity.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Diane L. Bolton, Sampa Santra, Cindy Swett-Tapia, Jerome Custers, Kaimei Song, Harikrishnan Balachandran, Linh Mach, Hussein Naim, Pamela A. Kozlowski, Michelle Lifton, Jaap Goudsmit, Norman Letvin, Mario Roederer, Katarina RadoÅ¡eviÄ,